Antigen 85B of Mycobacterium tuberculosis: From Immunodominant Antigen to Vaccine Candidate

Vivek Chauhan, Gaytri Mahajan, Rakesh Kumar, Shrikanth S. Gadad, Subhash C. Chauhan, Chinnaswamy Jagannath, Subramanian Dhandayuthapani · 2026

Read Antigen 85B of Mycobacterium tuberculosis: From Immunodominant Antigen to Vaccine Candidate by Vivek Chauhan, Gaytri Mahajan, Rakesh Kumar, Shrikanth S. Gadad, Subhash C. Chauhan, Chinnaswamy Jagannath, Subramanian Dhandayuthapani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13611855.txt.

Description

Vivek Chauhan and co-authors review antigen 85B, a protein of the tuberculosis germ, as a vaccine candidate, in a review paper from 2026. Tuberculosis still burdens world health despite working drugs. The only licensed vaccine, BCG, protects adults unevenly at best.

The protein helps the germ build its cell wall, stick to host cells, and stir immune response. Vaccine makers have placed it in subunit, DNA, mRNA, and live-carrier designs. Trials in animals and humans show strong cell-based immune response and often better protection. The review weighs the protein's biology and trial record, and argues it belongs at the center of next-generation tuberculosis vaccines.

Catalog record

CREATORVivek Chauhan, Gaytri Mahajan, Rakesh Kumar, Shrikanth S. Gadad, Subhash C. Chauhan, Chinnaswamy Jagannath, Subramanian Dhandayuthapani
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13611855

Browse the full library · About the Tower of Babel